- Home
- WLK vs BRKR Comparison
WLK vs BRKR Comparison
Compare WLK & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WLK | BRKR |
|---|---|---|
| Founded | 1986 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 9.0B |
| IPO Year | 2004 | 2000 |
Fundamental Metrics
Financial Performance| Metric | WLK | BRKR |
|---|---|---|
| Price | $70.33 | $62.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 13 |
| Target Price | ★ $106.87 | $48.54 |
| AVG Volume (30 Days) | 975.2K | ★ 1.9M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.90% | 0.58% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $11,170,000,000.00 | $1,895,600,000.00 |
| Revenue This Year | $5.51 | $6.30 |
| Revenue Next Year | $3.74 | $3.81 |
| P/E Ratio | ★ N/A | $3,214.75 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $56.33 | $28.53 |
| 52 Week High | $124.23 | $64.95 |
Technical Indicators
Market Signals| Indicator | WLK | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 24.28 | 55.01 |
| Support Level | $56.33 | $54.54 |
| Resistance Level | $79.57 | $64.18 |
| Average True Range (ATR) | 2.17 | 3.40 |
| MACD | -0.17 | 0.05 |
| Stochastic Oscillator | 9.33 | 71.00 |
Price Performance
Historical ComparisonAbout WLK Westlake Corporation
Westlake is a forward-integrated commodity chemicals firm based in Houston. It began as a single low-density polyethylene plant and expanded its capabilities to include ethylene, vinyl chloride monomers, and polyvinyl chloride over the next two decades. The acquisition of Axiall in 2016 made it a North American leader in chlor-alkali and PVC. Today, Westlake has two defined segments: performance and essential materials, and housing and infrastructure products. The HIP segment began operating in 2022 following a series of acquisitions in the building products space. The firm aims to maximize the value of its chemical production by integrating with the HIP segment, realizing the higher margins of finished commercial goods.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.